[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513231":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":93,"collaborators":96,"id":99,"slug":100,"hasResults":101,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":107,"sex":108,"minAge":109,"maxAge":110,"enrollmentInfo":111,"targetDuration":12,"studyType":114,"phases":115,"briefSummary":117,"conditions":118,"keywords":124,"overallStatus":42,"whyStopped":12,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":139},{"fullName":5,"class":6},"Ankara University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","NO_INTERVENTION","In eligible patients allocated to control group, no interventions will be done before ART cycle.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Ethanol sclerotherapy","EXPERIMENTAL","In eligible patients allocated to study group, endometrioma\u002Fs will be aspirated and treated with ethanol for 10 minutes 1-2 cycles before ART.",[18],"Procedure: Ethanol Sclerotherapy for Endometrioma",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"PROCEDURE","Ethanol Sclerotherapy for Endometrioma","2 gr IV cefazolin sodium will be administered 30 minutes before the procedure. The endometrioma cyst content will be aspirated by a single lumen needle, and the total aspirated volume calculation will be done. The endometrioma will then be washed with saline until the color of the cyst content becomes clear. Then, 96% ethanol will be injected into the cyst. The volume of injected ethanol will be 60% of the first aspirated volume (maximum 100 ml). After 10 minutes all ethanol will be aspirated.",[14],[26],{"name":27,"affiliation":5,"role":28},"Batuhan Aslan","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":12,"email":34},"Yavuz Emre Sukur","CONTACT","+905332409381","yesukur@gmail.com",{"name":36,"role":32,"phone":37,"phoneExt":12,"email":38},"Sezcan Mumusoglu","+905326404673","sezcanmumusoglu@gmail.com",[40,59,76],{"facility":41,"status":42,"city":43,"state":12,"zip":12,"country":44,"countryCode":12,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Başkent University Adana IVF Center","RECRUITING","Adana","Turkey (Türkiye)",{"type":46,"coordinates":47},"Point",[48,49],35.32531,36.98615,{"lat":49,"lon":48},[52,56],{"name":53,"role":32,"phone":54,"phoneExt":12,"email":55},"Erhan Şimşek, Assoc. Prof.","+90 533 414 62 99","drsimsekerhan@gmail.com",{"name":57,"role":58,"phone":12,"phoneExt":12,"email":12},"Gülşen Doğan Durdağ","SUB_INVESTIGATOR",{"facility":60,"status":42,"city":61,"state":12,"zip":62,"country":44,"countryCode":12,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Ankara University School of Medicine, Department of Obstetrics and Gynecology","Ankara","06610",{"type":46,"coordinates":64},[65,66],32.85427,39.91987,{"lat":66,"lon":65},[69,72],{"name":70,"role":32,"phone":71,"phoneExt":12,"email":34},"Yavuz Emre Şükür, M.D.","00905332409381",{"name":73,"role":32,"phone":74,"phoneExt":12,"email":75},"Batuhan Aslan, M.D.","00905462555335","drbatuhanaslan@gmail.com",{"facility":77,"status":42,"city":78,"state":12,"zip":12,"country":44,"countryCode":12,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Bahçeci IVF Clinic","Istanbul",{"type":46,"coordinates":80},[81,82],28.94966,41.01384,{"lat":82,"lon":81},[85,89,91],{"name":86,"role":32,"phone":87,"phoneExt":12,"email":88},"Özkan Özdamar","+90 532 476 67 44","ozkan_ozdamar@yahoo.com",{"name":90,"role":32,"phone":12,"phoneExt":12,"email":12},"Prof",{"name":92,"role":58,"phone":12,"phoneExt":12,"email":12},"Gürkan Bozdağ, Prof",{"type":28,"investigatorFullName":94,"investigatorTitle":95,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Yavuz Emre Şükür","associate professor",[97],{"name":98,"class":6},"Hacettepe University","100513231","ethanol-sclerotherapy-prior-to-art-100513231",false,"NCT05962775","Ethanol Sclerotherapy Prior to ART","The Impact of Ethanol Sclerotherapy Before ART (Assisted Reproductive Technology) Cycle on Cumulative Live Birth Rate in Infertile Women With Endometrioma: A Randomized Controlled Trial","START","Inclusion Criteria:\n\n* AMH\\>0.3 ng\u002Fml\n* unilateral\u002Fbilateral endometrioma\n* Endometrioma diameter 40-100 mm\n\nExclusion Criteria:\n\n* 3 or more IVF\u002Fembryo transfer failure\n* Menstrual cycle abnormalities\n* Male Factor infertility\n* Presence of uterine fibroids\n* Presence of hydrosalpinx\n* Presence of uterine abnormalities\n* Suspicion of malignancy according to International Ovarian Tumor Analysis criteria",true,"FEMALE","18 Years","40 Years",{"count":112,"type":113},84,"ESTIMATED","INTERVENTIONAL",[116],"NA","The goal of this randomized controlled trial is to assess the impact of ethanol sclerotherapy on ART cycle outcomes. The main questions it aims to answer are:\n\n1. Does ethanol sclerotherapy before ART cycle has any impact on cumulative live birth rate in patients with endometrioma?\n2. Does ethanol sclerotherapy improve chronic pelvic pain, dysmenorrhea, complications during oocyte retrieval, response to ovarian stimulation (number of mature oocytes retrieved), and pregnancy loss rates?\n\nInfertile patients with endometrioma between 4-10 cm who are scheduled for ART within 2 cycles will be randomized to ethanol sclerotherapy or no intervention.",[119,120,121,122,123],"Endometrioma","Infertility","Sclerotherapy","ART","IVF",[125,126,127,128,129],"endometrioma","ethanol sclerotherapy","assisted reproductive technology","in vitro fertilization","cumulative live birth rate","2024-10-13",{"date":132,"type":133},"2024-10-16","ACTUAL",{"date":135,"type":133},"2023-05-01",{"date":137,"type":113},"2026-04-01",{"name":5,"class":6},3]